Status: current, Defined. Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3298434017 | Parenteral form daunorubicin | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 3298499012 | Parenteral form daunorubicin (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 3488593010 | Product containing daunorubicin in parenteral dosage form (medicinal product form) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3497670010 | Product containing daunorubicin in parenteral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3497671014 | Daunorubicin in parenteral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3709449010 | Daunorubicin-containing product in parenteral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3709450010 | Product containing daunorubicin in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Daunorubicin-containing product in parenteral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Daunorubicin-containing product in parenteral dose form | Is a | Daunorubicin-containing product | true | Inferred relationship | Some | ||
| Daunorubicin-containing product in parenteral dose form | Is a | Product manufactured as parenteral dose form | true | Inferred relationship | Some | ||
| Daunorubicin-containing product in parenteral dose form | Has active ingredient | Daunorubicin | true | Inferred relationship | Some | 1 | |
| Daunorubicin-containing product in parenteral dose form | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Daunorubicin only product in parenteral dose form | Is a | True | Daunorubicin-containing product in parenteral dose form | Inferred relationship | Some | |
| Liposomal daunorubicin 2mg/mL injection emulsion 25mL vial | Is a | False | Daunorubicin-containing product in parenteral dose form | Inferred relationship | Some | |
| Daunorubicin (as daunorubicin hydrochloride) 20 mg powder for solution for injection vial | Is a | False | Daunorubicin-containing product in parenteral dose form | Inferred relationship | Some | |
| Daunorubicin (as daunorubicin hydrochloride) 5 mg/mL solution for injection | Is a | False | Daunorubicin-containing product in parenteral dose form | Inferred relationship | Some | |
| Liposomal daunorubicin 2mg/mL injection emulsion | Is a | False | Daunorubicin-containing product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR